33 results
424B3
HOTH
Hoth Therapeutics Inc
22 Apr 24
Prospectus supplement
4:15pm
the market, voluntary or mandatory recalls, a requirement to recall, replace or refund the cost of any product we manufacture or distribute, fines, suspension … clearance or approval, the agency has the authority to require the recall of commercialized products in the event of adverse side effects, material
8-K
EX-10.1
HOTH
Hoth Therapeutics Inc
15 Sep 23
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:15pm
of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
8-K
EX-10.1
k3gokzm6lpc5hgc4h1z6
30 Dec 22
Hoth Therapeutics Announces $10 Million Private Placement
4:15pm
8-K
EX-1.1
of5l8wbc3 hx9l
13 Apr 22
Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
5:11pm
8-K
EX-10.1
ca5oj40dmzcjz uj2n
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.1
r0nhg6h9
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
424B3
eo7uk3b8sjl
7 May 20
Prospectus supplement
6:02am
424B3
hx8nhu67
25 Oct 19
Prospectus supplement
5:12pm
424B3
517xm7fwwgcah
16 Sep 19
Prospectus supplement
5:06pm